Nuclea Biotechnologies, Inc. — Form D

Nuclea Biotechnologies, Inc. of PITTSFIELD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-12-17. The offering totals $4.0M, of which $425K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
James W LewisDirectorJersey City, NJ
Richard W VietorDirectorPittsfield, MA
William R HarmanDirectorNEW YORK, NY
Dennis K StoneDirectorHouston, TX
Richard R VietorDirectorSt. Louis, MO
Patrick J MuracaDirectorPittsfield, MA
Patrick J MuracaExecutive OfficerPittsfield, MA
Robert J PierceExecutive OfficerPittsfield, MA
Paula J EvansExecutive OfficerPittsfield, MA
Charles P StetsonDirectorPittsfield, MA
PAULA C EVANSExecutive OfficerPITTSFIELD, MA
Richard R. VietorDirectorPittsfield, MA
Patrick J. MuracaDirectorPittsfield, MA
Patrick J. MuracaExecutive OfficerPittsfield, MA
Robert J. PierceExecutive OfficerPittsfield, MA
Paula J. EvansExecutive OfficerPittsfield, MA
Charles P. StetsonDirectorPittsfield, MA
William R. HarmanDirectorPittsfield, MA

Other filings by this issuer (9)

FiledFormOfferingSold
2013-02-20D$1.1M
2012-08-08D$5.0M
2012-05-03D$555K
2012-04-11D$1.9M
2011-08-18D$3.0M
2010-12-08D
2010-11-01D/A$8.9M
2009-10-22D/A$3.4M
2009-06-24D$3.0M$1.0M

More